ClinConnect ClinConnect Logo
Search / Trial NCT06596109

Lifestyle Changes in Fatty Liver; Additive Effect of Honey Intake

Launched by CAIRO UNIVERSITY · Sep 11, 2024

Trial Information

Current as of July 26, 2025

Recruiting

Keywords

ClinConnect Summary

This clinical trial is looking at how lifestyle changes, particularly the addition of honey to the diet, can affect people with nonalcoholic fatty liver disease. Fatty liver is a condition where fat builds up in the liver, which can lead to health problems. Researchers want to see if honey, known for its health benefits, can help improve this condition in people who are obese.

To participate in the trial, individuals must have nonalcoholic fatty liver disease and be classified as obese, meaning they have a higher than normal amount of body fat. Both men and women aged between 18 and 26 years are eligible to join. Participants will be asked to make some lifestyle changes, including consuming honey, and will likely be monitored for how these changes impact their liver health. It's important to note that people with serious heart, lung, kidney, or leg issues cannot take part in this study. This trial could provide valuable insights into managing fatty liver disease through diet and lifestyle.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • fatty liver (non alcoholic form)
  • both sexes included
  • obese subjects (class I)
  • Exclusion Criteria:
  • cardiac insult
  • respiratory insult
  • renal insult
  • lower limb insult

About Cairo University

Cairo University, a premier institution in Egypt, is dedicated to advancing medical research and education through innovative clinical trials. With a strong emphasis on improving healthcare outcomes, the university collaborates with various stakeholders to conduct rigorous scientific studies that address critical health challenges. Leveraging its extensive resources and expert faculty, Cairo University aims to contribute valuable insights to the medical community and enhance patient care both locally and globally. Through its commitment to ethical research practices and excellence, the university plays a pivotal role in shaping the future of healthcare in the region.

Locations

Dokki, Giza, Egypt

Patients applied

0 patients applied

Trial Officials

Ali MA Ismail, lecturer

Principal Investigator

Cairo University

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported